sglt2 inhibitors and glp 1 receptor agonists Combining GLP-1 in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 vs GLP-1 for CKD:

[DOI] [PubMed] [Google Scholar] 217.Qualmann C., Nauck M.A., Holst J.J., Orskov C., Creutzfeldt W

This artificial sweetener may negatively impact the gut microbiome, though research is mixed

In addition, a meta-analysis was performed comparing pancreatitis events and exposure (patient-years) using Comprehensive Meta-Analysis version 2.2.064 (Englewood, NJ, USA), calculating the rate ratios and their 95% CIs, and the p value or difference

However, subtle differences exist based on their secondary receptor targets and clinical trial safety data

13:e0197321 [PMC free article: PMC5963790] [PubMed: 29787616] 272

doi: 10.1056/NEJMoa2307563 [DOI] [PubMed] [Google Scholar] 200